Skip to main content
logo
iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price on Aug 28, 2025

iTeos Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
-3512.6267.63344.78-
Revenue Growth
-177.89%-95.29%-22.38%--
Gross Profit
-3512.6267.63344.78-
Operating Income
-203.34-156.81-147.57127.5244.9-44.95
Net Income
-202.41-134.41-112.6496.65214.52-43.4
Earnings Per Share
-4.68-3.32-3.152.565.68-2.88
EPS Growth
----54.93%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
515.43494.65531.92613.16848.54336.33
Total Debt
5.135.16.064.675.34-
Net Cash (Debt)
510.3489.55525.86608.49843.2336.33
Net Cash Growth
-9.80%-6.90%-13.58%-27.83%150.71%1592.80%
Net Cash Per Share
11.7912.1014.7016.1122.3222.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-108.06-98.18-103.76-111.19513.14-25.18
Capital Expenditures
-0.63-1.63-2.97-0.94-1.18-0.36
Free Cash Flow
-108.69-99.81-106.72-112.13511.96-25.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-100.00%100.00%100.00%100.00%-
Operating Margin
--448.03%-1171.69%47.64%71.03%-
Pretax Margin
--343.83%-865.66%55.58%74.39%-
Profit Margin
--384.04%-894.34%36.11%62.22%-
FCF Margin
--285.18%-847.34%-41.90%148.49%-

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
---7.197.66-
Forward PE
----10.82-
P/FCF Ratio
----3.21-
PS Ratio
-8.0231.112.604.76-